PTI-801, a new drug candidate for chronic pain, enters development at Pain Therapeutics April 6, 2001
Recently issued international patent describes compounds for neurodegenerative disorders April 3, 2001
ACS news: Sch-211803, a potent and highly selective M2 antagonist selected for clinical development April 3, 2001